ホーム > 市場調査レポート > 医薬品

オーダーメイド医療

市場調査レポート

商品コード

1498771

個別化医療バイオマーカー市場：適応症別、用途別、エンドユーザー別、国別、地域別-産業分析、市場規模、市場シェア、2024～2032年予測

Personalized Medicine Biomarkers Market, By Indication, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 270 Pages
納期: 2～3営業日

カスタマイズ可能

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

レポートハイライト

個別化医療バイオマーカー市場規模は2023年に149億834万米ドルとなり、2024～2032年にかけてCAGR 14.30%で拡大

個別化医療バイオマーカー市場-市場力学

慢性疾患の有病率が上昇し、予後予測の重要性が認識されつつあることから、市場の成長が見込まれます。

がん、心血管疾患、糖尿病、神経変性疾患などの慢性疾患は世界規模で増加しています。テーラーメード医療は、これらの病気に対して正確で効率的な治療法を提供するもので、多くの場合、バイオマーカーを活用して個々の患者に合わせて治療法をカスタマイズします。米国国立保健統計センターによると、慢性疾患とは3ヵ月以上持続する状態を指します。約4,000万人のアメリカ人が、1つ以上の慢性的な健康問題によって日常生活に制限を受けています。予後バイオマーカーは疾病の転帰を予測するのに役立ち、臨床現場においてより多くの情報に基づいた意思決定を容易にします。さらに、政府機関や民間企業による個別化医療研究への投資の高まりが、新たなバイオマーカーや診断ツールの開発を後押しし、市場の成長機会を生み出しています。とはいえ、規制や償還に関する課題が市場の拡大を阻害する可能性もあります。

個別化医療バイオマーカー市場-主要洞察

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024～2032年）に約14.30%のCAGRで毎年成長すると推定されます。

適応症の別では、腫瘍が2023年に最大の市場シェアを示すと予測されました。

用途別では、早期発見・スクリーニングが2023年の主要タイプでした。

地域別では、北米が2023年の売上高でトップ

個別化医療バイオマーカー市場-セグメンテーション分析：

世界の個別化医療バイオマーカー市場は、適応症、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は、適応症に基づいて3つのセグメントに分類される：神経、腫瘍、糖尿病学、循環器、自己免疫疾患、その他です。同市場は主にがん領域が支配的です。個別化医療バイオマーカー市場は、特にがん領域において、技術の進歩とカスタマイズ型治療法に対するニーズの高まりにより、大幅な成長を遂げています。

市場は用途によって2つのセグメントに分類される：診断、治療の選択、早期発見・スクリーニング、モニタリングです。市場セグメンテーションの中で優位を占めるのは早期発見/スクリーニングです。早期発見・スクリーニング用バイオマーカーは、より早期かつ管理しやすい段階での疾患の特定を容易にし、患者の転帰の改善と医療費用の削減につながるため、その重要性はいくら強調してもし過ぎることはないです。

市場はエンドユーザーによって、病院・クリニックとその他の事業体の2つに区分されます。病院、クリニック、診断ラボは、診断精度と治療効果を向上させるためにバイオマーカーを活用する重要なエンドユーザーであり続けます。

個別化医療バイオマーカー市場：地理的洞察

地理的には、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカにまたがります。これらの地域は、事業活動に貢献している国によってさらに区分されます。同市場は、個別化医療に対する需要の高まりにより、主に北米が牽引しています。北米では、より効率的でカスタマイズ型治療オプションの必要性から、個別化医療に注目が集まっています。個別化医療は医療の個別化に努め、医療上の決定や治療を患者一人ひとりに合わせるものです。American Journal of Managed Careによると、2016～2020年にかけて全体として大きな成長が見られ、市場における個別化医薬品の数は132から286に増加しました。これらの医薬品は、2019年にFDAが承認した新薬の25％を占めています。欧州は、コンパニオン診断薬の採用が増加していることが要因で、市場成長の第2位の地域となっています。

個別化医療バイオマーカー市場-競合情勢：

個別化医療バイオマーカー市場の競合情勢は、様々な主要企業間の熾烈な競争によって特徴付けられます。これらの企業は、新たなバイオマーカーを発見し、高度な診断テストを開発するために、研究開発に多額の投資を行っています。このような絶え間ない技術革新は、市場で優位に立つために極めて重要です。ゲノミクス、プロテオミクス、バイオインフォマティクスの急速な進歩が市場を牽引しています。これらの技術を効果的に活用する企業は、競争優位に立つことができます。この競争の激しい市場において、大手企業は戦略的イニシアティブを通じて技術革新と能力拡大に努めています。企業が市場での地位を維持・強化するためには、継続的な技術の進歩、戦略的提携、規制当局の承認取得に注力することが不可欠です。

イントロダクション
北米
- 概要
- 北米の主要メーカー
- 米国
- カナダ
欧州
- 概要
- 欧州の主要メーカー
- ドイツ
- イタリア
- 英国
- フランス
- ロシア
- オランダ
- スウェーデン
- ポーランド
- その他
アジア太平洋
- 概要
- アジア太平洋の主要メーカー
- インド
- 中国
- 日本
- 韓国
- オーストラリア
- タイ
- インドネシア
- フィリピン
- その他
ラテンアメリカ
- 概要
- ラテンアメリカの主要メーカー
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他
中東・アフリカ
- 概要
- 中東・アフリカの主要メーカー
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- トルコ
- アルジェリア
- エジプト
- その他

第11章主要ベンダー分析-個別化医療バイオマーカー業界

競合ダッシュボード
企業プロファイル
- Siemens Healthineers
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Nexus-DX
- Qiagen
- PerkinElmer Inc.
- Lifesign LLC
- Merck &Co Inc.
- Bio-Rad Laboratories, Inc.
- EKF Diagnostics Holdings plc
- Singulex Inc.
- Signosis Inc.
- BioSims Technologies
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Illumina Inc.
- Myriad Genetics, Inc.
- Biomarker Technologies, Inc.
- Danaher Corporation
- Epigenomics AG
- その他

第12章アナリストの全方位展望

図表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Personalized Medicine Biomarkers Market: Indication Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Indication
TABLE Global Personalized Medicine Biomarkers Market, by Indication 2019-2032 (USD Million)
TABLE Personalized Medicine Biomarkers Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Personalized Medicine Biomarkers Market, by Application 2019-2032 (USD Million)
TABLE Personalized Medicine Biomarkers Market: End-User Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by End-User
TABLE Global Personalized Medicine Biomarkers Market, by End-User 2019-2032 (USD Million)
TABLE Personalized Medicine Biomarkers Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Personalized Medicine Biomarkers Market, by Region 2019-2032 (USD Million)
TABLE North America Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
TABLE North America Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
TABLE North America Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
TABLE North America Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)
TABLE Europe Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
TABLE Europe Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
TABLE Europe Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
TABLE Europe Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)
TABLE Asia Pacific Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
TABLE Asia Pacific Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)
TABLE Latin America Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
TABLE Latin America Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)
TABLE Middle East and Africa Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
TABLE Middle East and Africa Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)

Product Code: ANV2942

REPORT HIGHLIGHT

Personalized Medicine Biomarkers Market size was valued at USD 14,908.34 million in 2023, expanding at a CAGR of 14.30% from 2024 to 2032.

Personalized medicine, involving the use of biomarkers in clinical samples, is a fascinating field with important implications for drug development. Biomarkers act as measurable indicators of a biological state or condition, allowing for the prediction of disease risk, diagnosis of conditions, monitoring of disease progression, and guidance of treatment decisions. They are essential in personalized medicine, offering possibilities to improve patient outcomes through precise and individualized healthcare. Continuous progress in biomarker research and technology is driving the field ahead, leading to a future where treatments are tailored more and more to each patient's unique traits.

Personalized Medicine Biomarkers Market- Market Dynamics

The market is anticipated to experience growth due to the rising prevalence of chronic diseases and the increasing recognition of the significance of prognostic prediction

Chronic illnesses, such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders, are increasing on a global scale. Tailored medicine provides precise and efficient treatment options for these ailments, often utilizing biomarkers to customize therapies for individual patients. According to the U.S. National Center for Health Statistics, a chronic illness is a condition that persists for three months or longer. Approximately 40 million Americans face limitations in their daily activities due to one or more chronic health issues. Prognostic biomarkers aid in forecasting disease outcomes, facilitating more informed decision-making in clinical settings. Moreover, the heightened investment in personalized medicine research by both governmental and private sectors supports the advancement of new biomarkers and diagnostic tools, creating growth opportunities for the market. Nevertheless, challenges related to regulations and reimbursement may impede the market's expansion.

Personalized Medicine Biomarkers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.30% over the forecast period (2024-2032)

Based on Indication segmentation, Oncology was predicted to show maximum market share in the year 2023

Based on application segmentation, Early Detection/Screening was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Personalized Medicine Biomarkers Market- Segmentation Analysis:

The Global Personalized Medicine Biomarkers Market is segmented based on Indication, Application, End-User, and Region.

The market is categorized into three segments based on Indication: Neurology, Oncology, Diabetes, Cardiology, Autoimmune Diseases, and Others. The market is primarily dominated by the Oncology segment. The personalized medicine biomarkers market, particularly in the field of oncology, is witnessing substantial growth owing to technological advancements and a rising need for customized treatment methods.

The market is categorized into two segments according to their application: Diagnosis, Treatment Selection, Early Detection/Screening, and Monitoring. The dominant segment in the market is Early Detection/Screening. The significance of early detection and screening biomarkers cannot be overstated as they facilitate the identification of diseases at an earlier and more manageable stage, leading to better patient outcomes and decreased healthcare expenses.

The market is segmented into two distinct categories based on the end-user: hospitals and clinics, and other entities. Hospitals, clinics, and diagnostic laboratories will remain crucial end-users, utilizing biomarkers to improve diagnostic precision and treatment effectiveness.

Personalized Medicine Biomarkers Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market is predominantly led by North America, driven by the increasing demand for personalized medicine. There is a notable focus on personalized medicine in North America, spurred by the necessity for more efficient and customized treatment options. Personalized medicine strives to individualize healthcare, tailoring medical decisions and treatments to each patient. As per the American Journal of Managed Care, there has been significant growth overall from 2016 to 2020, with the number of personalized medicines in the market increasing from 132 to 286. These medicines represented 25% of the new drugs approved by the FDA in 2019. Europe follows as the second largest region for market growth, attributed to the rising adoption of Companion Diagnostics.

Personalized Medicine Biomarkers Market- Competitive Landscape:

The competitive landscape of the personalized medicine biomarkers market is characterized by fierce competition among various key players. These companies are making significant investments in research and development to discover new biomarkers and create advanced diagnostic tests. This constant innovation is crucial to stay ahead in the market. The market is being driven forward by rapid advancements in genomics, proteomics, and bioinformatics. Companies that effectively utilize these technologies can gain a competitive edge. In this highly competitive market, major players are striving to innovate and expand their capabilities through strategic initiatives. Continuous technological advancements, strategic collaborations, and a focus on obtaining regulatory approvals are vital for companies to maintain and strengthen their positions in the market.

Recent Developments:

On Monday, February 12, 2024, Abbott and Fujirebio announced their partnership to collaborate on the development of a research-use-only test for the neurofilament-light chain (NfL). In a joint statement, the companies revealed that this neurology biomarker assay will be compatible with Abbott's Alinity I instrument and will be made accessible to researchers engaged in studies that demonstrate the effectiveness of the NfL biomarker. The objective is to make this test commercially available by 2025, marking it as the inaugural RUO assay for the Alinity I system.

Biocartis, a Mechelen-based company in Belgium, has recently revealed an expanded alliance with Merck Serono Middle East and Merck Saudi Ltd., both subsidiaries of Merck KGaA, in the MEA region. The main aim of this partnership is to improve the accessibility of RAS biomarker testing for patients in the Middle East and North Africa.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Siemens Healthineers

F. Hoffmann-La Roche Ltd

Abbott Laboratories

Nexus-DX

Qiagen

PerkinElmer Inc.

Lifesign LLC

Merck & Co Inc.

Bio-Rad Laboratories, Inc.

EKF Diagnostics Holdings plc

Singulex Inc.

Signosis Inc.

BioSims Technologies

Agilent Technologies, Inc.

Thermo Fisher Scientific, Inc.

Illumina Inc.

Myriad Genetics, Inc.

Biomarker Technologies, Inc.

Danaher Corporation

Epigenomics AG

Others

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

Oncology
Neurology
Diabetes
Autoimmune Diseases
Cardiology
Others

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Early Detection/Screening
Diagnosis
Treatment Selection
Monitoring

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals and clinics
Others

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Personalized Medicine Biomarkers Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Personalized Medicine Biomarkers Market Snippet by Indication
- 2.1.2. Personalized Medicine Biomarkers Market Snippet by Application
- 2.1.3. Personalized Medicine Biomarkers Market Snippet by End-User
- 2.1.4. Personalized Medicine Biomarkers Market Snippet by Country
- 2.1.5. Personalized Medicine Biomarkers Market Snippet by Region
2.2. Competitive Insights

3. Personalized Medicine Biomarkers Key Market Trends

3.1. Personalized Medicine Biomarkers Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Personalized Medicine Biomarkers Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Personalized Medicine Biomarkers Market Opportunities
3.4. Personalized Medicine Biomarkers Market Future Trends

4. Personalized Medicine Biomarkers Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Personalized Medicine Biomarkers Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Personalized Medicine Biomarkers Market Landscape

6.1. Personalized Medicine Biomarkers Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Personalized Medicine Biomarkers Market - By Indication

7.1. Overview
- 7.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
- 7.1.2. Oncology
- 7.1.3. Neurology
- 7.1.4. Diabetes
- 7.1.5. Autoimmune Diseases
- 7.1.6. Cardiology
- 7.1.7. Others

8. Personalized Medicine Biomarkers Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Early Detection/Screening
- 8.1.3. Diagnosis
- 8.1.4. Treatment Selection
- 8.1.5. Monitoring

9. Personalized Medicine Biomarkers Market - By End-User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 9.1.2. Hospitals and clinics
- 9.1.3. Others

10. Personalized Medicine Biomarkers Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Personalized Medicine Biomarkers Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Personalized Medicine Biomarkers Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Personalized Medicine Biomarkers Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Personalized Medicine Biomarkers Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Personalized Medicine Biomarkers Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Personalized Medicine Biomarkers Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Siemens Healthineers
- 11.2.2. F. Hoffmann-La Roche Ltd
- 11.2.3. Abbott Laboratories
- 11.2.4. Nexus-DX
- 11.2.5. Qiagen
- 11.2.6. PerkinElmer Inc.
- 11.2.7. Lifesign LLC
- 11.2.8. Merck & Co Inc.
- 11.2.9. Bio-Rad Laboratories, Inc.
- 11.2.10. EKF Diagnostics Holdings plc
- 11.2.11. Singulex Inc.
- 11.2.12. Signosis Inc.
- 11.2.13. BioSims Technologies
- 11.2.14. Agilent Technologies, Inc.
- 11.2.15. Thermo Fisher Scientific, Inc.
- 11.2.16. Illumina Inc.
- 11.2.17. Myriad Genetics, Inc.
- 11.2.18. Biomarker Technologies, Inc.
- 11.2.19. Danaher Corporation
- 11.2.20. Epigenomics AG
- 11.2.21. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

個別化医療バイオマーカー市場：適応症別、用途別、エンドユーザー別、国別、地域別-産業分析、市場規模、市場シェア、2024～2032年予測

Personalized Medicine Biomarkers Market, By Indication, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

全表示

レポートハイライト

個別化医療バイオマーカー市場-セグメンテーション分析：

個別化医療バイオマーカー市場-競合情勢：

目次

第1章 個別化医療バイオマーカー市場概要

第2章 エグゼクティブ概要

第3章 個別化医療バイオマーカーの主要市場動向

第4章 個別化医療バイオマーカー産業研究

第5章 個別化医療バイオマーカー市場： COVID-19の影響分析

第6章 個別化医療バイオマーカー市場情勢

第7章 個別化医療バイオマーカー市場-適応症別

第8章 個別化医療バイオマーカー市場-用途別

第9章 個別化医療バイオマーカー市場-エンドユーザー別

第10章 個別化医療バイオマーカー市場-地域別

第11章 主要ベンダー分析-個別化医療バイオマーカー業界

第12章 アナリストの全方位展望